BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27049874)

  • 1. Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy.
    Fleshner K; Assel M; Benfante N; Lee J; Vickers A; Fine S; Carlsson S; Eastham J
    J Urol; 2016 Sep; 196(3):703-8. PubMed ID: 27049874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
    Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
    J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].
    Ojea Calvo A; Núñez López A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Gómez-González MC; González Piñeiro A; Otero García M; Nogueira March JL
    Actas Urol Esp; 2003 Jun; 27(6):428-37. PubMed ID: 12918149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
    Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
    J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
    Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
    J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.
    ElShafei A; Nyame Y; Kara O; Badawy A; Amujiogu I; Fareed K; Klein E; Jones JS
    J Urol; 2016 Jun; 195(6):1767-72. PubMed ID: 26724397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection.
    Vargas SO; Jiroutek M; Welch WR; Nucci MR; D'Amico AV; Renshaw AA
    Am J Clin Pathol; 1999 Feb; 111(2):223-8. PubMed ID: 9930144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology.
    Tonttila PP; Kuisma M; Pääkkö E; Hirvikoski P; Vaarala MH
    Scand J Urol; 2018 Apr; 52(2):111-115. PubMed ID: 29291666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active Surveillance.
    Hassan O; Han M; Zhou A; Paulk A; Sun Y; Al-Harbi A; Alrajjal A; Baptista Dos Santos F; Epstein JI
    J Urol; 2018 Jun; 199(6):1482-1487. PubMed ID: 29154905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer.
    Okihara K; Kamoi K; Lane RB; Evans RB; Troncoso P; Babaian RJ
    J Clin Ultrasound; 2002; 30(3):123-31. PubMed ID: 11948567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer polar localization on core biopsy predicts pathologic stage.
    Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
    Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater.
    Nakanishi H; Troncoso P; Babaian RJ
    J Urol; 2008 Dec; 180(6):2441-5; discussion 2445-6. PubMed ID: 18930495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perineural invasion by prostate cancer on MR/US fusion targeted biopsy is associated with extraprostatic extension and early biochemical recurrence after radical prostatectomy.
    Truong M; Rais-Bahrami S; Nix JW; Messing EM; Miyamoto H; Gordetsky JB
    Hum Pathol; 2017 Aug; 66():206-211. PubMed ID: 28705708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineural invasion status, Gleason score and number of positive cores in biopsy pathology are predictors of positive surgical margin following laparoscopic radical prostatectomy.
    Yang R; Cao K; Han T; Zhang YF; Zhang GT; Xu LF; Lian HB; Li XG; Guo HQ
    Asian J Androl; 2017; 19(4):468-472. PubMed ID: 27004537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.
    Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Franck Lissbrant I; Stattin P; Egevad L
    Pathology; 2017 Dec; 49(7):715-720. PubMed ID: 29037803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
    Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
    Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probability of extraprostatic disease according to the percentage of positive biopsy cores in clinically localized prostate cancer.
    Valette TN; Antunes AA; Leite KM; Srougi M
    Int Braz J Urol; 2015; 41(3):449-54. PubMed ID: 26200538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.